A mouse study shows cocaine takes over an existing brain circuit for mouth and face movements, locking behavior into rigid, ...
AbbVie's Juvmo (tavapadon) receives FDA approval as the first selective D1/D5 agonist for Parkinson's disease treatment.
Researchers have identified a brain circuit that normally supports flexible behavior, but is recruited by cocaine to drive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results